Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?

J. Pascual; W. Arns

首页> 外文期刊>American Journal of Transplantation >Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?

【24h】

Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?

机译：依维莫司是否会增加肾脏移植受者中特定于供体的HLA抗体？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

No abstract is available for this article.

机译：本文没有摘要。

著录项

来源
《American Journal of Transplantation》 |2012年第9期|2561-2562|共2页
作者
J. Pascual; W. Arns;
展开▼
作者单位

Servicio de Nefrología Hospital del Mar Barcelona Spain;

Medizinische Klinik I–Nephrologie Klinikum Köln-Merheim Universitt Witten-Herdecke Köln Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Does everolimus increase donor-specific HLA antibodies in kidney transplant recipients? [J] . J Pascual, W Arns American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2012,第9期

机译：依维莫司会增加肾移植受者的供体特异性HLA抗体吗？
2. IDENTIFICATION OF IMMUNOGENIC RECIPIENT HLA CLASS II AND DONOR-HLA-DERIVED PEPTIDE COMPLEXES: CLINICAL RELEVANCE TO DE NOVO DONOR-SPECIFIC HLA ANTIBODY FORMATION IN KIDNEY TRANSPLANTATION [J] . Tomosugi Toshihide, Iwasaki Kenta, Futamura Kenta, Transplant international : . 2019,第S2期

机译：免疫原性受体HLA II类和供体-HLA衍生的肽复合物的鉴定：肾移植中De Novo供体特异性HLA抗体形成的临床相关性
3. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients [J] . H. Kishikawa, T. Kinoshita, M. Hashimoto, Transplantation Proceedings . 2018,第8期

机译：II类HLA EPLET Mispatch是De Novo供体特异性抗体发育和肾移植受体中抗体介导的抑制剂的危险因素
4. TREATMENT OF REFRACTORY ANTIBODY MEDIATED REJECTION WITH BORTEZOMIB IN TWO TRANSPLANT RECIPIENTS: THE IMPACT ON DONOR-SPECIFIC ANTI-HLA ANTIBODIES [C] . John Lunz, Judy Howe, Lawrence Jelinek, Clinical Histocompatibility Workshop. . 2010

机译：治疗难治性抗体在两个移植受者中用硼替佐米介导的抑制剂：对供体特异性抗HLA抗体的影响
5. Eplet Mismatches and De Novo Donor-Specific Antibody Development in Pediatric Kidney Transplant Recipients [D] . Blanchette, Eliza 2019

机译：小儿肾移植受者的EPLET不匹配和De Novo供体特异性抗体发育
6. Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients [O] . Alexander H. Morrison, Meera Gupta, Kelsey Lloyd, 2019

机译：弱反应性移植前供体特异性HLA抗体的类别和动力学预测肾脏移植受者的排斥反应
7. Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients? [O] . J. Pascual, W. Arns 2012

机译：everolimus是否会增加肾移植受者的供体特异性HLA抗体？
8. Studies on the Antigenicity of Bone. II. Donor-Specific Anti-HLA Antibodies in Human Recipients of Freeze-Dried Allografts [R] . Friedlaender, G. E., Strong, D. M., Sell, K. W. 1984

机译：骨的抗原性研究。 II。冻干同种异体移植物的人类受体中的供体特异性抗HLa抗体

Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?

摘要

著录项

相似文献

相关主题

期刊订阅